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The neglected tropical diseases (NTDs)
are the most common infections of poor
people in developing countries, where they
cause a high disease burden that rivals
HIV/AIDS, tuberculosis, or malaria [1].
The NTDs also exhibit important poverty-
promoting features, a consequence of their
ability to adversely affect child develop-
ment, pregnancy outcome, and worker
productivity [1,2]. Over the last two
decades or more, several important quan-
titative indicators have been used to mea-
sure these health and economic conse-
quences. Employment of the disability-
adjusted life year (DALY) has facilitated a
comparison of NTD disease burden with
better known conditions, while several
estimates oftheeconomicimpact ofselected
NTDs, including hookworm infection, lym-
phatic filariasis, and trachoma, have pro-
vided insights on how these conditions
prevent the poorest people in developing
countries from escaping poverty [2].
There is also a third component to the
NTDs that may be just as important as the
health and economic effects of these
diseases, but it is one that so far has been
the least tangible and difficult to measure.
I am referring to the horrific social stigma
associated with many of the NTDs,
particularly highly disfiguring diseases
such as Buruli ulcer, leprosy, lymphatic
filariasis, and onchocerciasis. The link
between stigma and the NTDs go back
to our earliest recorded history [3]. The
medical detective and writer Berton
Roueche observed that in addition to
multiple biblical references to ‘‘unclean’’
people with leprosy, an ancient Egyptian
pharoah was known to banish people with
leprosy to edges of the Saharan Desert. He
coined the term lepraphobia to describe
how, at the height of the leprosy epidemic
in Europe in the 12th to14th century,
affected individuals were often subjected
to their own mock funeral prior to
banishment from their families and com-
munities [4]. In some cases, they endured
torture and execution [4].
Our concepts and definitions of what
exactly stigma means have changed over
time. In his landmark treatise entitled
Stigma: Notes on the Management of Spoiled
Identity, the social scientist Erving Goffman
noted that the original use of the term
came from the Greek and referred to a
scar made with a pointed instrument,
usually signifying an inferior social or
moral status, such as being a criminal,
traitor, or slave [5]. In early Christian
times the use of the term was broadened to
indicate a mark of disgrace or physical
disorder, presumably with lepraphobia in
mind, and later to a more modern
definition that linked stigma to disqualifi-
cation from social acceptance, either for
physical or social reasons [5,6]. Professor
Mitchell Weiss at the Swiss Tropical
Institute now defines health-related stigma
as ‘‘a social process or related personal
experience characterized by exclusion,
rejection, blame, or devaluation that
results from experience or reasonable
anticipation of an adverse social judgment
about a person or group identified with a
particular problem’’ [7]. Further, ‘‘the
judgment is medically unwarranted with
respect to the health problem itself, just as
stigma targeting other aspects of group
identity is also unwarranted ...’ ’[7].
Over the last decade, several key papers
have emerged that illustrate how the
stigma resulting from specific NTDs con-
tributes substantially to disease burden and
even poverty [8–11]. A common mecha-
nism is the exacerbation of disease and
suffering that result from significant delays
in seeking medical attention. For instance,
Jorge Alvar and his colleagues at the
World Health Organization and the US
Centers for Disease Control and Preven-
tion recently pointed out that women have
a higher disease burden from leishmaniasis
than men because of reduced health care
access, and because of their heightened
social isolation from the disfigurement
caused bythe cutaneousformof the disease,
which can prevent a young woman from
being permitted to touch her children, enter
into marriage, or remain married [3,9].
Similarly, a team from Groningen Univer-
sity Hospital in the Netherlands has elo-
quently described how the disfiguring
wounds of Buruli ulcer in Africa cause
affected individuals to attempt to hide their
disease because of the belief that it results
from witchcraft or the ‘‘evil eye,’’ and as a
result such individuals seek neither medical
attention nor employment [3,9]. In a
previous issue of PLoS Neglected Tropical
Diseases, we published a revealing study by
Myrtle Perera and her colleagues, who
noted how the stigma resulting from the
disability and disfigurement of lymphatic
filariasis causes affected individuals to avoid
free government clinics leading to worsened
illness, reduced career aspirations, and
ultimately, an inexorable downward spiral
to poverty [11].
In an upcoming issue of PLoS Neglected
Tropical Diseases, Professor Weiss provides a
fresh look at stigma and the social burden of
NTDs by looking at some of the disease-
specific elements of stigma, including cul-
tural meanings for infections such as
leprosy, or how some of the more common
disfiguring NTDs such as Buruli ulcer,
leishmaniasis, lymphatic filariasis, and on-
chocerciasis produce stigmata primarily
from physical features [12]. He further
suggests a new framework for looking at
how the known elements of stigma that
results fromthese infections might provide a
basis for establishing an effective health
policy that is just as attentive to the social
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and medical ones [12]. To my mind,
Professor Weiss makes the case that ad-
dressing these social underpinnings of the
NTDs could be almost as important for
achieving Millennium Development Goals
and sustainable poverty reduction as mass
drugadministrationandthedevelopmentof
new vaccines and other control tools [1]. I
am not alone. In his previous role as
Director of the Fogarty International Cen-
ter of the US National Institutes of Health,
Professor Gerald Keusch (now Deputy
Provost for Global Health at Boston
University) launched an innovative pro-
gram tofund proposalson theroleof stigma
in health and disease. The Fogarty initiative
recognizes that the social burden of disease
occurs disproportionately in developing
countries, that the type and degree of
stigma vary across the disease condition,
the country, and the culture, and that there
is not a ‘‘one size fits all’’ interdisciplinary
approach to reduce stigma [13,14]. Of
particular importance, these factors can
potentially be addressed by high-quality
social science research and evidence-based
approaches [13,14].
An important stimulus for establishing
PLoS Neglected Tropical Diseases was the
recognition that these conditions, possibly
more than any other, are linked to social
factors that rank in importance with the
biological factors of the parasites and their
hosts, the clinical features, and the large-
scale approaches that rely on preventive
chemotherapy and vector control. All of
these factors relate to the concept of
reducing the suffering from NTDs as a
fundamental human right [1,15]. We
therefore continue to strongly encourage
papers with solid, evidence-based social
research as it applies to the NTDs.
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